Page last updated: 2024-10-21

mercaptoethanol and Kidney Diseases

mercaptoethanol has been researched along with Kidney Diseases in 15 studies

Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
" We observed this acute toxic effect despite the administration of sufficient mesna to prevent hemorrhagic cystitis."1.27Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna. ( Goren, MP; Horowitz, ME; Pratt, CB; Wright, RK, 1987)
"Thirty-two patients with advanced cancer were treated in a phase I-II trial with ifosfamide plus mesnum."1.26Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment. ( Falkson, G; Falkson, HC; Stapelberg, R; Van Dyk, JJ, 1982)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199015 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, XP1
Foulkes, EC1
Hilgard, P1
Burkert, H1
Brock, N1
Stekar, J1
Falkson, G2
Van Dyk, JJ1
Stapelberg, R1
Falkson, HC1
Bird, GW1
Wingham, J1
Goren, MP2
Pratt, CB2
Meyer, WH1
Wright, RK2
Dodge, RK1
Viar, MJ1
Horowitz, ME1
Kempf, SR2
Ivankovic, S2
Alberts, AS1
Van Zyl, L1
Wiessler, M1
Schmähl, D1
Waller, M1
Moncure, CW1
Call, FL1
Williams, WJ1
Koffler, D1
Carr, R1
Agnello, V1
Thoburn, R1
Kunkel, HG1
Clark, H1
Ronald, AR1
Turck, M1
Tannenberg, AM1
Wicher, KJ1
Rose, NR1

Other Studies

15 other studies available for mercaptoethanol and Kidney Diseases

ArticleYear
Specificity of acute effects of Cd on renal function.
    Toxicology, 1984, Apr-02, Volume: 30, Issue:3

    Topics: Animals; Cadmium; Cadmium Chloride; Cytochrome c Group; Female; Kidney Diseases; Male; Mercaptoethan

1984
Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:11

    Topics: Cyclophosphamide; Humans; Ifosfamide; Infusions, Parenteral; Kidney Diseases; Mercaptoethanol; Mesna

1984
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Arzneimittel-Forschung, 1982, Volume: 32, Issue:5

    Topics: Animals; Cyclophosphamide; Ifosfamide; Kidney Diseases; Mercaptoethanol; Mesna; Oxidation-Reduction;

1982
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.
    Cancer chemotherapy and pharmacology, 1982, Volume: 9, Issue:2

    Topics: Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Mercap

1982
Anti-A autoantibodies with unusual properties in a patient on renal dialysis.
    Immunological communications, 1980, Volume: 9, Issue:2

    Topics: ABO Blood-Group System; Adult; Agglutination; Antibodies; Autoantibodies; Female; Humans; Kidney Dis

1980
Mesna excretion and ifosfamide nephrotoxicity in children.
    Cancer research, 1989, Dec-15, Volume: 49, Issue:24 Pt 1

    Topics: Adolescent; Adult; Child; Child, Preschool; Creatinine; Female; Humans; Ifosfamide; Kidney Diseases;

1989
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
    Cancer treatment reports, 1987, Volume: 71, Issue:2

    Topics: Acetylglucosaminidase; Adolescent; Adult; Aminopeptidases; CD13 Antigens; Child; Child, Preschool; C

1987
Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.
    Cancer treatment reviews, 1987, Volume: 14, Issue:3-4

    Topics: Animals; Cisplatin; Kidney Diseases; Kidney Neoplasms; Mercaptoethanol; Mesna; Rats

1987
Malignant pleural mesothelioma: phase II pilot study of ifosfamide and mesna.
    Journal of the National Cancer Institute, 1988, Jul-06, Volume: 80, Issue:9

    Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Diseases; Male; Mercapt

1988
Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
    British journal of cancer, 1985, Volume: 52, Issue:6

    Topics: Animals; Cisplatin; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; Mercaptoethanol; Mesn

1985
The association of the serum agglutinators with the fast IgG globulins.
    Immunochemistry, 1973, Volume: 10, Issue:2

    Topics: Abscess; Antibodies, Anti-Idiotypic; Antibody Specificity; Chromatography, Ion Exchange; Cysteine; E

1973
Phosphatidate phosphatase in human platelets.
    The Journal of laboratory and clinical medicine, 1973, Volume: 82, Issue:4

    Topics: Blood Platelets; Buffers; Edetic Acid; Erythrocytes; Freezing; Glycerophosphates; Humans; Hydrogen-I

1973
Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.
    The Journal of experimental medicine, 1971, Jul-01, Volume: 134, Issue:1

    Topics: Animals; Antibodies, Antinuclear; Antibody Specificity; Antigens; Antigens, Bacterial; Antigens, Vir

1971
Serum antibody response in renal versus bladder bacteriuria.
    The Journal of infectious diseases, 1971, Volume: 123, Issue:5

    Topics: Antibodies; Bacteriuria; Escherichia coli Infections; Female; Hemagglutination Tests; Humans; Kidney

1971
Ampicillin nephropathy.
    JAMA, 1971, Oct-18, Volume: 218, Issue:3

    Topics: Ampicillin; Antibody Specificity; Antigen-Antibody Reactions; Carbuncle; Child; Chromatography, Gel;

1971